Skip to main content

Table 1 Summary of prevalence results by age grouping

From: The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

Age Group First author & publication year Geography Number DMD identified Prevalence date Mean prevalence per 100,000 Type of prevalence
Newborn Mendell, 2012 [2] Ohio 6 2007–2011 15.9 Birth
Moat, 2013 [3] Wales 72 1990–2011 19.5
Boys aged 5 to 9 Romitti, 2015 [14] USA 111 1991–1995 14.3 5 - year
117 1996–2000 14.6
127 2001–2005 16.0
141 2006–2010 11.8
Boys aged 5 to 24 Romitti, 2015 [14] USA 389 2010 10.2 Point
Males under 18 Rasmussen, 2012 [13] SE Norway 33 2005 16.2
Males 0 to 24 Mah, 2011 [15] Canada 529 2000–2009 10.3
All Males Norwood FL, 2009 [12] Northern England 124 2007 8.3
Bladen 2013 [16]* France 3337 2012 10.9
USA 2833 2012 1.8
UK 666 2012 2.2
Canada 1020 2012 6.1
  1. *Reported in Bladen [16] but based on web-based registry data